Genus/£GNS
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Genus
Genus PLC, trading under the ticker GNS on the London Stock Exchange, specializes in animal genetics and biotechnology. The company, founded in 1994 and headquartered in Basingstoke, United Kingdom, operates across multiple countries offering genetically superior pig and cattle breeding stock along with state-of-the-art in vitro fertilization products. Genus PLC aims to empower customers in the livestock sector to enhance the efficiency and profitability of their operations by providing innovative genetic solutions and services.
Ticker
£GNS
Sector
Primary listing
LSE
Industry
Biotechnology
Headquarters
Employees
3,500
ISIN
GB0002074580
Website
Genus Metrics
BasicAdvanced
£1.4B
-
-£0.06
0.48
£0.32
1.47%
Price and volume
Market cap
£1.4B
Beta
0.48
52-week high
£22.45
52-week low
£14.24
Average daily volume
178K
Dividend rate
£0.32
Financial strength
Current ratio
1.939
Quick ratio
1.257
Long term debt to equity
54.357
Total debt to equity
57.63
Interest coverage (TTM)
2.73%
Profitability
EBITDA (TTM)
75
Gross margin (TTM)
38.43%
Net profit margin (TTM)
-0.60%
Operating margin (TTM)
9.26%
Effective tax rate (TTM)
-16.36%
Revenue per employee (TTM)
£190,000
Management effectiveness
Return on assets (TTM)
3.81%
Return on equity (TTM)
-1.18%
Valuation
Price to revenue (TTM)
2.13
Price to book
2.8
Price to tangible book (TTM)
4.18
Price to free cash flow (TTM)
45.705
Free cash flow yield (TTM)
2.19%
Free cash flow per share (TTM)
47.59%
Dividend yield (TTM)
1.47%
Growth
Revenue change (TTM)
-0.22%
Earnings per share change (TTM)
-112.14%
3-year revenue growth (CAGR)
5.63%
10-year revenue growth (CAGR)
5.61%
3-year earnings per share growth (CAGR)
-52.20%
10-year earnings per share growth (CAGR)
-19.27%
10-year dividend per share growth (CAGR)
5.75%
What the Analysts think about Genus
Analyst ratings (Buy, Hold, Sell) for Genus stock.
Bulls say / Bears say
Genus achieved a 16% increase in revenue to £689.7 million in 2023, indicating strong demand for its products. (businesswire.com)
The company reported a 10% rise in adjusted operating profit, reflecting effective cost management and operational efficiency. (businesswire.com)
Genus's PRRS-resistant pig program is progressing well, with favorable regulatory decisions in Brazil and Colombia, and ongoing discussions with the US FDA, positioning the company for future growth. (businesswire.com)
Net income declined by 19% to £33.3 million in 2023, indicating potential profitability challenges. (simplywall.st)
The profit margin decreased from 6.9% to 4.8%, suggesting increased costs or pricing pressures. (simplywall.st)
PIC China's operating profit decreased by 60% due to market difficulties and supply chain investments, highlighting regional vulnerabilities. (businesswire.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jul 2025.
Genus Financial Performance
Revenues and expenses
Genus Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Genus stock?
Genus (GNS) has a market cap of £1.4B as of July 11, 2025.
What is the P/E ratio for Genus stock?
The price to earnings (P/E) ratio for Genus (GNS) stock is 0 as of July 11, 2025.
Does Genus stock pay dividends?
Yes, the Genus (GNS) stock pays dividends to shareholders. As of July 11, 2025, the dividend rate is £0.32 and the yield is 1.47%. Genus has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Genus dividend payment date?
The next Genus (GNS) dividend payment date is unconfirmed.
What is the beta indicator for Genus?
Genus (GNS) has a beta rating of 0.48. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.